Recursion Pharmaceuticals, a biotech start-up in Salt Lake City, today announced the appointment of Robert Lollini, MBA, CPA, to its business advisory panel. Mr. Lollini is a distinguished leader in the life sciences, having served as President and Chief Executive Officer of IOMED, Inc. and Myrexis, Inc. Currently Mr. Lollini serves as the Chief Financial Officer of BioFire Diagnostics, a clinical diagnostics company recently acquired by the multinational biotechnology company BioMérieux.
Help employers find you! Check out all the jobs and post your resume.
